drugset / Trial / NCT07491393
Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology
RandomizedCrossoverOpen-labelOther
Summary
Nefopam is a non-opioid analgesic approved for the symptomatic treatment of acute pain, particularly postoperative pain. The HAS has authorized nefopam tablet, while emphasizing the lack of bibliographic data on both the pharmacokinetic and clinical aspects. The aim of this study is to evaluate the pharmacokinetics of nefopam tablets.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2027-04-07
- Completion
- 2027-04-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nefopam | Small molecule | 30 mg | Intravenous |
Indications
No indication recorded.